1. Home
  2. LLY
  3. LLY News

Latest Eli Lilly and Company (LLY) News on June 23, 2025

Lilly expects orforglipron obesity results in third quarter
LLY

Reuters

2 days ago

Lilly expects orforglipron obesity results in third quarter

Lilly's oral GLP-1, orforglipron, showed compelling efficacy and a safety profile consistent with injectable GLP-1 medicines, in complete Phase 3 results published in The New England Journal of Medicine
LLY

PR Newswire

2 days ago

Lilly's oral GLP-1, orforglipron, showed compelling efficacy and a safety profile consistent with injectable GLP-1 medicines, in complete Phase 3 results published in The New England Journal of Medicine

LLY

MT Newswires

3 days ago

S&P 500 Edges Down Weekly as Declines Led by Health Care Outweigh Energy-Led Gains

LLY

MT Newswires

3 days ago

Sector Update: Health Care Stocks Retreat Late Afternoon

Muscle-preserving drugs could generate over $30 billion in sales by 2035, TD Cowen says
LLY

Reuters

3 days ago

Muscle-preserving drugs could generate over $30 billion in sales by 2035, TD Cowen says

A $1.3 Billion Reason to Buy Eli Lilly Stock Now
LLY

Barchart

3 days ago

A $1.3 Billion Reason to Buy Eli Lilly Stock Now

LLY

MT Newswires

3 days ago

Sector Update: Health Care Stocks Softer in Afternoon Trading

LLY

MT Newswires

3 days ago

Sector Update: Health Care

LLY

MT Newswires

3 days ago

Market Chatter: Lilly to Appeal Against UK Regulator's Recommendation Not to Reimburse Cost of Alzheimer's Drug

This AI Trader Bought Meta Stock and Dumped Eli Lilly
LLY

Barrons.com

4 days ago

This AI Trader Bought Meta Stock and Dumped Eli Lilly

LLY

MT Newswires

4 days ago

Market Chatter: Eli Lilly Says Indian Market's Response to Weight-Loss Drug Mounjaro is 'Positive'

Eli Lilly says India response to obesity drug Mounjaro is 'positive', will focus on meeting demand
LLY

Reuters

4 days ago

Eli Lilly says India response to obesity drug Mounjaro is 'positive', will focus on meeting demand

Eli Lilly (NYSE:LLY) Faces $7 Billion Lawsuit While Partnering With Innovative Biotech
LLY

Simply Wall St.

4 days ago

Eli Lilly (NYSE:LLY) Faces $7 Billion Lawsuit While Partnering With Innovative Biotech

What is the Intent Behind Eli Lilly's Recent M&A Deals Spree?
LLY

Zacks

4 days ago

What is the Intent Behind Eli Lilly's Recent M&A Deals Spree?

SanDisk initiated, Analog Devices upgraded: Wall Street’s top analyst calls
LLY

TipRanks

4 days ago

SanDisk initiated, Analog Devices upgraded: Wall Street’s top analyst calls

RyboDyn Selected to Join Lilly Gateway Labs to Advance Next-Gen Immunotherapies Targeting the Dark Proteome
LLY

PR Newswire

4 days ago

RyboDyn Selected to Join Lilly Gateway Labs to Advance Next-Gen Immunotherapies Targeting the Dark Proteome

Trump administration weighs crackdown on pharma ads, Bloomberg says
LLY

TipRanks

5 days ago

Trump administration weighs crackdown on pharma ads, Bloomberg says

Novo Nordisk Just Improved Its Weight-Management Pipeline: Is the Stock a Buy?
LLY

Motley Fool

5 days ago

Novo Nordisk Just Improved Its Weight-Management Pipeline: Is the Stock a Buy?

Move Over Hims & Hers Health: This Insurance Business Could Be the Next Monster Healthcare Stock (Hint: It's Not UnitedHealth)
LLY

Motley Fool

6 days ago

Move Over Hims & Hers Health: This Insurance Business Could Be the Next Monster Healthcare Stock (Hint: It's Not UnitedHealth)

Adam Parker of Trivariate Research Recommends Eli Lilly’s Dividend as a Defensive Play
LLY

Insider Monkey

6 days ago

Adam Parker of Trivariate Research Recommends Eli Lilly’s Dividend as a Defensive Play

Podcast: U.S. Stocks Slip as Israel-Iran Conflict Continues
LLY

The Wall Street Journal

6 days ago

Podcast: U.S. Stocks Slip as Israel-Iran Conflict Continues

These Stocks Moved the Most Today: Sunrun, Enphase, Verve Therapeutics, Palantir, Tesla, T-Mobile, Jabil, and More
LLY

Barrons.com

6 days ago

These Stocks Moved the Most Today: Sunrun, Enphase, Verve Therapeutics, Palantir, Tesla, T-Mobile, Jabil, and More

Verve Therapeutics Skyrockets — Pulling Gene-Editing Stocks Higher — On $1.3 Billion Eli Lilly Takeover
LLY

Investor's Business Daily

6 days ago

Verve Therapeutics Skyrockets — Pulling Gene-Editing Stocks Higher — On $1.3 Billion Eli Lilly Takeover

Solar stocks, Eli Lilly & Verve, PureCycle: Trending Tickers
LLY

Yahoo Finance Video

6 days ago

Solar stocks, Eli Lilly & Verve, PureCycle: Trending Tickers

These Stocks Are Moving the Most Today: Sunrun, Enphase, Verve Therapeutics, Palantir, T-Mobile, Lennar, Jabil, and More
LLY

Barrons.com

6 days ago

These Stocks Are Moving the Most Today: Sunrun, Enphase, Verve Therapeutics, Palantir, T-Mobile, Lennar, Jabil, and More

LLY

MT Newswires

6 days ago

Sector Update: Health Care Stocks Decline Premarket Tuesday

Eli Lilly Strikes up to $1.3 Billion Deal to Buy Verve Therapeutics
LLY

MT Newswires

6 days ago

Eli Lilly Strikes up to $1.3 Billion Deal to Buy Verve Therapeutics

LLY

MT Newswires

6 days ago

Fed Policy-Setting Meeting Begins as US Equity Futures Decline Pre-Bell

LLY

MT Newswires

6 days ago

Sector Update: Health Care

Verve Therapeutics Stock Soars as Eli Lilly Buys Gene-Editing Firm for $1.3B
LLY

Investopedia

6 days ago

Verve Therapeutics Stock Soars as Eli Lilly Buys Gene-Editing Firm for $1.3B

LLY

MT Newswires

6 days ago

Exchange-Traded Funds, Equity Futures Lower Pre-Bell Tuesday Amid Escalating Iran-Israel Conflict

LLY

MT Newswires

8 days ago

Eli Lilly to Start Providing Higher-Dose Zepbound Variants

3 Growth Stocks You Can Buy Right Now Without Any Hesitation
LLY

Motley Fool

8 days ago

3 Growth Stocks You Can Buy Right Now Without Any Hesitation

Lilly to offer all approved doses of Zepbound (tirzepatide) single-dose vials through LillyDirect Self Pay Pharmacy Solutions
LLY

PR Newswire

8 days ago

Lilly to offer all approved doses of Zepbound (tirzepatide) single-dose vials through LillyDirect Self Pay Pharmacy Solutions

Pharma manufacturing 'boom' faces high costs, potential delays
LLY

Yahoo Finance

8 days ago

Pharma manufacturing 'boom' faces high costs, potential delays

Eli Lilly Just Made Another Move to Dominate the Weight Loss Market: Should You Buy the Stock?
LLY

Motley Fool

9 days ago

Eli Lilly Just Made Another Move to Dominate the Weight Loss Market: Should You Buy the Stock?

1 Growth Stock Down 9% to Buy Right Now
LLY

Motley Fool

10 days ago

1 Growth Stock Down 9% to Buy Right Now

Top Analyst Reports for Eli Lilly, Home Depot & SAP
LLY

Zacks

10 days ago

Top Analyst Reports for Eli Lilly, Home Depot & SAP

Novo Nordisk Is Europe’s Most Valuable Company—Again. Eli Lilly, Watch Out.
LLY

Barrons.com

10 days ago

Novo Nordisk Is Europe’s Most Valuable Company—Again. Eli Lilly, Watch Out.

Senators to propose ban on drug ads to consumers, WSJ reports
LLY

TipRanks

10 days ago

Senators to propose ban on drug ads to consumers, WSJ reports

Lilly Moves Past 50-Day Average: Should You Buy the Stock Now?
LLY

Zacks

10 days ago

Lilly Moves Past 50-Day Average: Should You Buy the Stock Now?

Tariffs Create Most Patriotic Earnings Season Yet as US Firms Pander to Trump
LLY

Bloomberg

10 days ago

Tariffs Create Most Patriotic Earnings Season Yet as US Firms Pander to Trump

NVO Stock up on Plans to Advance Obesity Candidate Amycretin
LLY

Zacks

10 days ago

NVO Stock up on Plans to Advance Obesity Candidate Amycretin

Down 12%, Should You Buy the Dip on Eli Lilly?
LLY

Motley Fool

11 days ago

Down 12%, Should You Buy the Dip on Eli Lilly?

Abbott Laboratories Stock Sees RS Rating Rise To 82
LLY

Investor's Business Daily

11 days ago

Abbott Laboratories Stock Sees RS Rating Rise To 82

Eli Lilly (NYSE:LLY) Collaborates With Juvena To Enhance Muscle Health Through AI Technology
LLY

Simply Wall St.

12 days ago

Eli Lilly (NYSE:LLY) Collaborates With Juvena To Enhance Muscle Health Through AI Technology

Trump Trade: RFK Jr. removes members of vaccine-advising CDC panel
LLY

TipRanks

12 days ago

Trump Trade: RFK Jr. removes members of vaccine-advising CDC panel

Can Mounjaro, Zepbound Help Lilly Maintain Dominance in Obesity Space?
LLY

Zacks

12 days ago

Can Mounjaro, Zepbound Help Lilly Maintain Dominance in Obesity Space?

Eli Lilly telehealth partners continue to sell compounded GLP-1 weight-loss drugs despite agreement not to
LLY

Yahoo Finance

12 days ago

Eli Lilly telehealth partners continue to sell compounded GLP-1 weight-loss drugs despite agreement not to

Should You Buy Eli Lilly Stock Before June 22?
LLY

Motley Fool

13 days ago

Should You Buy Eli Lilly Stock Before June 22?

The cheap fat jabs sending big pharma into a frenzy
LLY

The Telegraph

13 days ago

The cheap fat jabs sending big pharma into a frenzy

Eli Lilly telehealth deals to prevent sale of compounded GLP-1s
LLY

Yahoo Finance Video

13 days ago

Eli Lilly telehealth deals to prevent sale of compounded GLP-1s

LLY

MT Newswires

13 days ago

Sector Update: Health Care Stocks Rise Late Afternoon

LLY

Investing.com

13 days ago

Hims & Hers stock falls after Lilly rules out partnership

LLY

MT Newswires

13 days ago

Update: Market Chatter: Lilly to Only Work With Telehealth Companies That Don't Sell Copycat Zepbound

Drug pricing reform talks with US government lack clarity, industry executives say
LLY

Reuters

13 days ago

Drug pricing reform talks with US government lack clarity, industry executives say

McDonald's Stock Bitten By Big Downgrade Over Weight-Loss Drugs
LLY

Investor's Business Daily

13 days ago

McDonald's Stock Bitten By Big Downgrade Over Weight-Loss Drugs

2 Weight Loss Drug Stocks That Are Screaming Buys in June
LLY

Motley Fool

14 days ago

2 Weight Loss Drug Stocks That Are Screaming Buys in June

Eli Lilly Bets $870 Million on Extended-Release Obesity Drugs
LLY

GuruFocus.com

14 days ago

Eli Lilly Bets $870 Million on Extended-Release Obesity Drugs

Obesity Newcomer Metsera Enters The Ring With A Punch — And A Big Stock Jump
LLY

Investor's Business Daily

14 days ago

Obesity Newcomer Metsera Enters The Ring With A Punch — And A Big Stock Jump

Eli Lilly and Company (LLY): A Bull Case Theory
LLY

Insider Monkey

14 days ago

Eli Lilly and Company (LLY): A Bull Case Theory

Was Jim Cramer Right to Favor Another Stock Over Viking Therapeutics (VKTX)?
LLY

Insider Monkey

14 days ago

Was Jim Cramer Right to Favor Another Stock Over Viking Therapeutics (VKTX)?

Obesity Newcomer Metsera, Up 23%, Enters The Ring With A Punch
LLY

Investor's Business Daily

14 days ago

Obesity Newcomer Metsera, Up 23%, Enters The Ring With A Punch

Eli Lilly and Company (LLY) Is a Trending Stock: Facts to Know Before Betting on It
LLY

Zacks

14 days ago

Eli Lilly and Company (LLY) Is a Trending Stock: Facts to Know Before Betting on It

Eli Lilly's Obesity Drug Success Spurs Japanese Biotech's Anti-Muscle-Wasting Combo Therapy
LLY

Benzinga

14 days ago

Eli Lilly's Obesity Drug Success Spurs Japanese Biotech's Anti-Muscle-Wasting Combo Therapy

LLY

MT Newswires

15 days ago

Market Chatter: Eli Lilly Weight-Loss Drug India Sales Jump 60% in May From April

5 Monster Stocks to Hold for the Next 10 Years
LLY

Motley Fool

15 days ago

5 Monster Stocks to Hold for the Next 10 Years

The biggest obesity deals of 2025 so far
LLY

Pharma Voice

15 days ago

The biggest obesity deals of 2025 so far

Billionaire Stanley Druckenmiller Has Unloaded Shares of Last Year's 2 Top Performing AI Stocks and Is Piling Into a Growth Stock That Has Climbed 150% in 3 Years
LLY

Motley Fool

16 days ago

Billionaire Stanley Druckenmiller Has Unloaded Shares of Last Year's 2 Top Performing AI Stocks and Is Piling Into a Growth Stock That Has Climbed 150% in 3 Years

LLY

Morningstar Research

17 days ago

Analyst Report: Eli Lilly and Company

Challenges pharma companies face in push into US manufacturing
LLY

Yahoo Finance Video

17 days ago

Challenges pharma companies face in push into US manufacturing

The Next Look At Amgen's Obesity Drug Is Coming. Here's What Investors Are Watching.
LLY

Investor's Business Daily

17 days ago

The Next Look At Amgen's Obesity Drug Is Coming. Here's What Investors Are Watching.

Is Novo Nordisk's Next Generation Obesity Pipeline a Game Changer?
LLY

Zacks

17 days ago

Is Novo Nordisk's Next Generation Obesity Pipeline a Game Changer?

Salesforce initiated, Dollar Tree upgraded: Wall Street’s top analyst calls
LLY

TipRanks

17 days ago

Salesforce initiated, Dollar Tree upgraded: Wall Street’s top analyst calls

Was Jim Cramer Right About Novo Nordisk A/S (NVO)?
LLY

Insider Monkey

17 days ago

Was Jim Cramer Right About Novo Nordisk A/S (NVO)?

Rare Outflow Signals Hit Eli Lilly Shares
LLY

FX Empire

18 days ago

Rare Outflow Signals Hit Eli Lilly Shares

Novo Nordisk Stock: Is It Still a Smart Buy?
LLY

Motley Fool

18 days ago

Novo Nordisk Stock: Is It Still a Smart Buy?

Branded Pharmaceuticals Stocks Q1 In Review: Collegium Pharmaceutical (NASDAQ:COLL) Vs Peers
LLY

StockStory

18 days ago

Branded Pharmaceuticals Stocks Q1 In Review: Collegium Pharmaceutical (NASDAQ:COLL) Vs Peers

Eli Lilly (LLY)’s Target Price Slashed to $960 by TD Cowen, Reiterates Buy Rating
LLY

Insider Monkey

18 days ago

Eli Lilly (LLY)’s Target Price Slashed to $960 by TD Cowen, Reiterates Buy Rating

Agency warns that weight-loss drugs can decrease effectiveness of birth control pills
LLY

Fortune

18 days ago

Agency warns that weight-loss drugs can decrease effectiveness of birth control pills

Pre-Tariff Pharma Stockpiling Gives Irish Economy a Huge Booster Shot
LLY

The Wall Street Journal

18 days ago

Pre-Tariff Pharma Stockpiling Gives Irish Economy a Huge Booster Shot

REGN Strengthens Obesity Pipeline: Will the Move Revive the Stock?
LLY

Zacks

18 days ago

REGN Strengthens Obesity Pipeline: Will the Move Revive the Stock?

LLY

MT Newswires

19 days ago

TD Cowen Adjusts Price Target on Eli Lilly and Company to $960 From $1,050, Maintains Buy Rating

Should You Invest $1,000 in Eli Lilly today?
LLY

Motley Fool

19 days ago

Should You Invest $1,000 in Eli Lilly today?

These 7 Stocks Are Analyst Favorites For Magnificent Earnings Growth; Broadcom Results Ahead
LLY

Investor's Business Daily

19 days ago

These 7 Stocks Are Analyst Favorites For Magnificent Earnings Growth; Broadcom Results Ahead

Lilly partners with Camurus in search of a long-lasting obesity drug
LLY

BioPharma Dive

20 days ago

Lilly partners with Camurus in search of a long-lasting obesity drug

1 Underrated Reason to Buy This Market-Beating Stock
LLY

Motley Fool

20 days ago

1 Underrated Reason to Buy This Market-Beating Stock

Prediction: Eli Lilly Will Reach a $1 Trillion Valuation by 2027
LLY

Motley Fool

20 days ago

Prediction: Eli Lilly Will Reach a $1 Trillion Valuation by 2027

LLY

MT Newswires

20 days ago

Eli Lilly, Camurus Collaborate to Develop Therapies for Cardiometabolic Health

Eli Lilly (NYSE:LLY) Advances Ovarian Cancer Treatment And Transfers Cialis Rights In Latin America
LLY

Simply Wall St.

20 days ago

Eli Lilly (NYSE:LLY) Advances Ovarian Cancer Treatment And Transfers Cialis Rights In Latin America

Lilly to participate in Goldman Sachs 46th Annual Global Health Care Conference
LLY

PR Newswire

21 days ago

Lilly to participate in Goldman Sachs 46th Annual Global Health Care Conference

LLY

MT Newswires

21 days ago

Lilly Reports 55% Response Rate in Ovarian Cancer Drug Trial

Lilly presents first clinical data for its investigational, next-generation FRα targeting ADC in platinum-resistant ovarian cancer at the 2025 ASCO Annual Meeting
LLY

PR Newswire

21 days ago

Lilly presents first clinical data for its investigational, next-generation FRα targeting ADC in platinum-resistant ovarian cancer at the 2025 ASCO Annual Meeting

Weight Loss Drug ETF (THNR) Hits New 52-Week High
LLY

Zacks

22 days ago

Weight Loss Drug ETF (THNR) Hits New 52-Week High

Could Viking Therapeutics Become the Next Eli Lilly?
LLY

Motley Fool

22 days ago

Could Viking Therapeutics Become the Next Eli Lilly?

LLY

MT Newswires

22 days ago

DBS Bank Adjusts Price Target on Eli Lilly and Company to $900 From $1,010, Maintains Buy Rating

Pharma Stock Roundup: LLY's New Deal, GSK & SNY's Pipeline Updates
LLY

Zacks

24 days ago

Pharma Stock Roundup: LLY's New Deal, GSK & SNY's Pipeline Updates

3 American Growth Giants to Invest in for the Long Haul
LLY

Motley Fool

25 days ago

3 American Growth Giants to Invest in for the Long Haul

How Ozempic maker Novo Nordisk fell behind Eli Lilly in the weight loss drug race
LLY

Quartz

25 days ago

How Ozempic maker Novo Nordisk fell behind Eli Lilly in the weight loss drug race

Lilly announces details of presentations at American Diabetes Association's (ADA) 85th Scientific Sessions
LLY

PR Newswire

25 days ago

Lilly announces details of presentations at American Diabetes Association's (ADA) 85th Scientific Sessions

Share on Social Networks: